BDMAI

Infinite Right-to-Left Scrolling Marquee
Latest Circulars

Availability of QC Manpower trained in BDMA T & T Center

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Simplification of license procedure to manufacture new drug or investigational new drug for clinical trial or bioavailability or bioequivalence study or for examination, test and analysis

Workshop for Bench Chemists

Nomination for Internal Committees of BDMAI

Availability of QC Manpower trained in BDMA T & T Center

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Simplification of license procedure to manufacture new drug or investigational new drug for clinical trial or bioavailability or bioequivalence study or for examination, test and analysis

Workshop for Bench Chemists

Nomination for Internal Committees of BDMAI

Representations

1                                               Representation to DCGI, CDSCO on Various issues                        06.06.2025                                         Click Here

   2                                              Renewal of Return Confirmation for EU                                               31 .05.2025                                    Click Here    

   3                                             Drug Manufacturing License against Export NoC                          28.05.32025                                          Click Here

.

    4                                           Revised Guidelines for Export NoC                                                         31.03.2025                                            Click Here

    5                                           Implementation of Environmental Laws by State Boards               04.04.2025                                          Click Here

 

 

    6                                           Representation to Narcotics Commissioner                                         10.02.2025                                          Click Here

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

© 2021 Templately copyright all right reserved